Lynk Pharma Gets NDA Acceptance for Zemprocitinib by NMPA
Lynk Pharmaceuticals Co., Ltd. (“Lynk Pharmaceuticals”), a clinical-stage innovative drug development company focused on therapies for immune and inflammatory diseases, today announced that the New...